Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Po

NV-387, A Broad-Spectrum Antiviral with Strong Activity Against RSV, Influenza A, Coronaviruses, Others SHELTON, CT / ACCESSWIRE / May 20, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the strong antiviral activity of N...

Related Keywords

United States ,Japan ,American ,Japanese ,Palivizumab Synagis ,Securities Exchange ,Committee For Medicinal Products Human ,Drug Administration ,Theracour Pharma Inc ,Exchange Commission ,European Medicines Agency ,Nanoviricides Inc ,Pfizer ,Broad Spectrum Antiviral ,Strong Activity Against ,Human Immunodeficiency Virus ,Hepatitisb Virus ,Hepatitisc Virus ,Herpes Simplex Virus ,Varicella Zoster Virus ,Asian Bird Flu Virus ,Japanese Encephalitis ,West Nile Virus ,Theracour Pharma ,Securities Act ,Securities Exchange Act ,United States Securities ,Good Manufacturing ,Medicinal Products ,Human Use ,Relations Contact ,